Atlas Trials

Pharmacia and Upjohn

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Pharmacia and Upjohn

RecordFirmDate
A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies (NCT00002210)Pharmacia and Upjohn
A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3 (NCT00002123)Pharmacia and Upjohn
A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients (NCT00002236)Pharmacia and Upjohn
Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals (NCT00002087)Pharmacia and Upjohn
The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine (NCT00002312)Pharmacia and Upjohn
A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3 (NCT00002124)Pharmacia and Upjohn
A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients (NCT00002401)Pharmacia and Upjohn
Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients (NCT00002211)Pharmacia and Upjohn
A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients (NCT00002322)Pharmacia and Upjohn
Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201E (NCT00002094)Pharmacia and Upjohn
A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients (NCT00002400)Pharmacia and Upjohn

Track Pharmacia and Upjohn automatically

Every clearance here is in the API, with alerts when new ones post.